Time in range is a tool for assessing the quality of glycemic control in diabetes

Time in range is a tool for assessing the quality of glycemic control in diabetes

The presence of continuous glucose monitoring (CGM) systems has expanded diagnostic capabilities. The implementation of this technology into clinical practice allowed to determine the patterns and tendencies of excursions in glucose levels, to obtain reliable data concerning short-term glycemic cont...

Full description

Bibliographic Details
Main Authors:	L. A. Suplotova, A. S. Sudnitsyna, N. V. Romanova, M. V. Shestakova
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2021-09-01
Series:	Сахарный диабет
Subjects:	time in range diabetes continuous glucose monitoring
Online Access:	https://www.dia-endojournals.ru/jour/article/view/12703

Similar Items

The role Time in range depending on the method of assessing glycemic control in diabetes: A review
by: Lyudmila A. Suplotova, et al.
Published: (2022-06-01)

Analysis of time in range depending on the method of assessing the glucose level
by: L. A. Suplotova, et al.
Published: (2021-05-01)

Variation of glucose time in range in type 1 diabetes
by: Klavs Würgler Hansen, et al.
Published: (2022-11-01)

Modern methods for assessing compensation of diabetes mellitus. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes
by: N.V. Pasyechko, et al.
Published: (2023-12-01)

Time in range as a useful marker for evaluating retinal functional changes in diabetic retinopathy patients
by: Dan-Dan Zhu, et al.
Published: (2023-06-01)

Comparison of glucose time in range and area under curve in range in relation to risk of diabetic retinopathy in type 2 diabetes patients
by: Yaxin Wang, et al.
Published: (2022-09-01)

Relationship Between Time in Range and Dusk Phenomenon in Outpatients with Type 2 Diabetes Mellitus
by: Gao X, et al.
Published: (2023-06-01)

Time in range: a new parameter to evaluate blood glucose control in patients with diabetes
by: Monica Andrade Lima Gabbay, et al.
Published: (2020-03-01)

Time in range, especially overnight time in range, is associated with sudomotor dysfunction in patients with type 1 diabetes
by: Zhou-qin Feng, et al.
Published: (2021-10-01)

Beyond A1C: exploring continuous glucose monitoring metrics in managing diabetes
by: Jared G Friedman, et al.
Published: (2023-06-01)

Relationship between Time in Range and Long-term HbA1c Glycemic Variability in Elderly Male Patients with Type 2 Diabetes
by: FANG Fusheng, LIU Xingyu, YAN Shuangtong, WANG Ning, LI Chunlin, TIAN Hui
Published: (2023-06-01)

Differential correlation between time in range and eGFR or albuminuria in type 2 diabetes
by: Xuguang Jin, et al.
Published: (2023-05-01)

Analysis of the quality of life of patients with type 1 diabetes mellitus in real clinical practice who received insulin degludec
by: L. A. Suplotova, et al.
Published: (2021-10-01)

Association between low‐carbohydrate diets and continuous glucose monitoring‐derived time in ranges
by: Keiko Osugi, et al.
Published: (2023-05-01)

Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study
by: Norihiro Kuroda, et al.
Published: (2021-02-01)

The Scientific Advisory board resolution: Implementation of intermittently scanned Continuous Glucose monitoring in clinical practice to improve glycemic control
by: V. A. Peterkova, et al.
Published: (2021-07-01)

Socioeconomic status and time in glucose target range in people with type 2 diabetes: a baseline analysis of the GP-OSMOTIC study
by: Mei Lyn Tan, et al.
Published: (2018-07-01)

Rethinking Carbohydrate Intake and Time in Range in Children and Adolescents with Type 1 Diabetes
by: Valentino Cherubini, et al.
Published: (2021-10-01)

Association of time in range with hemoglobin A1c, glycated albumin and 1,5‐anhydro‐d‐glucitol
by: Mana Ohigashi, et al.
Published: (2021-06-01)

How to Measure Glycemic Variability? A Literature Review
by: Sandra Lazar, et al.
Published: (2023-12-01)

Real-Time Flash Glucose Monitoring Had Better Effects on Daily Glycemic Control Compared With Retrospective Flash Glucose Monitoring in Patients With Type 2 Diabetes on Premix Insulin Therapy
by: Reng-na Yan, et al.
Published: (2022-02-01)

Frequent scanning using flash glucose monitoring contributes to better glycemic control in children and adolescents with type 1 diabetes
by: Tatsuhiko Urakami, et al.
Published: (2022-01-01)

Preserved C-peptide secretion is associated with higher time in range (TIR) on intermittently scanned continuous glucose monitoring in Chinese adults with type 1 diabetes
by: Wei Liu, et al.
Published: (2022-10-01)

Correlation of Glycemic Variability and Time in Range with Early Neurological Deterioration in Patients with Acute Ischemic Stroke and Diabetes
by: Ming WANG, Zhi XI, Qizhe MENG, Xiaopeng YANG
Published: (2022-04-01)

Understanding glycemic variability: Focus on diabetic kidney disease
by: Vedavati Bharat Purandare, et al.
Published: (2021-01-01)

Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter?
by: Yifei Mo, et al.
Published: (2024-01-01)

Accuracy and impact on quality of life of real-time continuous glucose monitoring in children with hyperinsulinaemic hypoglycaemia
by: Madhini Sivasubramanian, et al.
Published: (2023-09-01)

A Review of Research Progress on Glycemic Variability and Gestational Diabetes
by: Yu W, et al.
Published: (2020-08-01)

COMPARISON OF THE RESULTS OF BLOOD GLUCOSE SELFMONITORING AND CONTINUOUS GLUCOSE MONITORING IN PREGNANT WOMEN WITH PREVIOUS DIABETES MELLITUS
by: A. V. Dreval', et al.
Published: (2016-02-01)

Time in range, assessed with continuous glucose monitoring, is associated with brachial-ankle pulse wave velocity in type 2 diabetes: A retrospective single-center analysis
by: Hui Zhou, et al.
Published: (2022-10-01)

Correlation between time in range and serum uric acid in Chinese patients with type-2 diabetes: an observational cross-sectional study
by: Yan Liu, et al.
Published: (2024-03-01)

Leveraging advances in diabetes technologies in primary care: a narrative review
by: Bruce Bode, et al.
Published: (2021-01-01)

Association of glycemic variability assessed by continuous glucose monitoring with subclinical diabetic polyneuropathy in type 2 diabetes patients
by: Jiemin Pan, et al.
Published: (2022-02-01)

Dysglycemia in adults at risk for or living with non-insulin treated type 2 diabetes: Insights from continuous glucose monitoring
by: Souptik Barua, et al.
Published: (2021-05-01)

Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on “time in range” in patients with type 2 diabetes
by: Yongru Chen, et al.
Published: (2024-03-01)

The association between time in the glucose target range and abnormal ankle-brachial index: a cross-sectional analysis
by: Yinghua Wei, et al.
Published: (2022-12-01)

Use of Continuous Glucose Monitors to Manage Type 1 Diabetes Mellitus: Progress, Challenges, and Recommendations
by: Friedman JG, et al.
Published: (2023-03-01)

Serum Metabolomics Reveals a Potential Benefit of Methionine in Type 1 Diabetes Patients with Poor Glycemic Control and High Glycemic Variability
by: Liyin Zhang, et al.
Published: (2023-01-01)

Validation of a Probabilistic Prediction Model for Patients with Type 1 Diabetes Using Compositional Data Analysis
by: Alvis Cabrera, et al.
Published: (2023-03-01)

Continuous Glucose Monitoring in Patients Following Simultaneous Pancreas–Kidney Transplantation: Time in Range and Glucose Variability
by: Ilya V. Dmitriev, et al.
Published: (2023-04-01)